Enter assignee name

EPO Patents = 4

Forward Citations = 4

Loading Chart...

9 inventors (with patents filed for the assignee):

Cornelis Johannes Leenhouts (4 out of 15 patents)

Petrus Josephus Marie Rottier (3 out of 4 patents)

Bert Jan Haijema (3 out of 3 patents)

4. Cornelis Alexander Maria De Haan (3 out of 3 patents)

5. Ronald De Groot (2 out of 2 patents)

6. Peter Wilhelmus Maria Hermans (2 out of 2 patents)

7. Govert Johan Schouten (1 out of 17 patents)

8. Maarten Leonardus Van Roosmalen (1 out of 2 patents)

9. Berend Jan Bosch (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. RE47471 - Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions (2019-07-01),

2. 9878034 - Adjuvanted vaccine formulations (2018-01-30),

3. 9585953 - Immunogenic compositions in particulate form and methods for producing the same (2017-03-07),

4. 9549974 - Method for selecting and producing vaccine components and vaccines based thereon (2017-01-24),

5. 9060975 - Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions (2015-06-23),

6. 8142789 - Method for selecting and producing vaccine components and vaccines based thereon (2012-03-27),

Mucosis B.V. is a clinical stage biotechnology company developing a revolutionary platform for needle-free vaccination. Using their patented Mimopath technology, they are able to develop highly effective mucosal vaccines for respiratory and other infectious diseases. Their goal is to provide safe, convenient, and cost-effective vaccines that can reach a broader population worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

6 Patents

#10 in Groningen

#946 in Netherlands

Groningen, Netherlands

Mucosis B.v.